UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Membrane-associated farnesylated UCH-L1 promotes α-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (12), p.4635-4640

2009

Volltextzugriff (PDF)

Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein

The Journal of biological chemistry, 2008-06, Vol.283 (24), p.16895-16905

2008

Volltextzugriff (PDF)

The Impact of the E46K Mutation on the Properties of α-Synuclein in Its Monomeric and Oligomeric States

Biochemistry (Easton), 2007-06, Vol.46 (24), p.7107-7118

2007

Volltextzugriff (PDF)

Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing

Bioorganic & medicinal chemistry letters, 2017-12, Vol.27 (23), p.5230-5234

2017

Volltextzugriff (PDF)

Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516

Bioorganic & medicinal chemistry letters, 2018-02, Vol.28 (3), p.533-536

2018

Volltextzugriff (PDF)

Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A

Toxicon (Oxford), 2017-10, Vol.137, p.36-47

2017

Volltextzugriff (PDF)

Botulinum neurotoxin serotype A inhibitors: Small-molecule mercaptoacetamide analogs

Bioorganic & medicinal chemistry, 2009-04, Vol.17 (8), p.3072-3079

2009

Volltextzugriff (PDF)

Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid

The AAPS journal, 2012-09, Vol.14 (3), p.510-518

2012

Volltextzugriff (PDF)

Molecular Cloning and Sequence Analysis of the Complestatin Biosynthetic Gene Cluster

Proceedings of the National Academy of Sciences - PNAS, 2001-07, Vol.98 (15), p.8548-8553

2001

Volltextzugriff (PDF)

Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy

The Journal of clinical investigation, 2008-02, Vol.118 (2), p.777-788

2008

Volltextzugriff (PDF)

PPARδ modulation rescues mitochondrial fatty acid oxidation defects in the mdx model of muscular dystrophy

Mitochondrion, 2019-05, Vol.46, p.51-58

2019

Volltextzugriff (PDF)

Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)

ACS medicinal chemistry letters, 2018-09, Vol.9 (9), p.935-940

2018

Volltextzugriff (PDF)

Correction to “Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)”

ACS medicinal chemistry letters, 2019-06, Vol.10 (6), p.1013-1013

2019

Volltextzugriff (PDF)

Membrane-associated farnesylated UCH-L1 promotes [alpha]-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (12), p.4635

2009

Volltextzugriff (PDF)

Membrane-associated farnesylated UCH-L1 promotes Î±-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease

Proceedings of the National Academy of Sciences - PNAS, 2009, Vol.106 (12), p.4635-4640

2009

Volltextzugriff (PDF)

Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope

Infection and immunity, 1998-09, Vol.66 (9), p.4374-4381

1998

Volltextzugriff (PDF)

Developing a Clinical Biomarker Method with External Resources

Biomarkers in Drug Discovery and Development, 2020, p.43-50

2020

Volltextzugriff (PDF)

Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-SynucleinS

The Journal of biological chemistry, 2008-06, Vol.283 (24), p.16895-16905

2008

Volltextzugriff (PDF)

Dopamine-modified [alpha]-synuclein blocks chaperone-mediated autophagy

The Journal of clinical investigation, 2008-02, Vol.118 (2), p.777

2008

Volltextzugriff (PDF)

Impaired degradation of mutant [alpha]-synuclein by chaperone-mediated autophagy

Science (American Association for the Advancement of Science), 2004-08, Vol.305 (5688), p.1292-1295

2004

Volltextzugriff (PDF)

Isolation and Characterization of Two Proteins fromMoraxella catarrhalis That Bear a Common Epitope

Infection and Immunity, 1998-09, Vol.66 (9), p.4374-4381

1998

Volltextzugriff (PDF)

An evaluation of the molecular model of alpha-synuclein-mediated cytotoxicity

Fredenburg, Ross Allen

2006

Volltextzugriff (PDF)

Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations

Journal of chromatography. B, Biomedical sciences and applications, 2001-04, Vol.753 (2), p.269-278

2001

Volltextzugriff (PDF)

Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of Î±-Synuclein

The Journal of biological chemistry, 2008-06, Vol.283 (24), p.16895

2008

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Membrane-associated farnesylated UCH-L1 promotes α-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease

Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein

The Impact of the E46K Mutation on the Properties of α-Synuclein in Its Monomeric and Oligomeric States

Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing

Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516

Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A

Botulinum neurotoxin serotype A inhibitors: Small-molecule mercaptoacetamide analogs

Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid

Molecular Cloning and Sequence Analysis of the Complestatin Biosynthetic Gene Cluster

Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy

PPARδ modulation rescues mitochondrial fatty acid oxidation defects in the mdx model of muscular dystrophy

Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)

Correction to “Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)”

Membrane-associated farnesylated UCH-L1 promotes [alpha]-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease

Membrane-associated farnesylated UCH-L1 promotes Î±-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease

Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope

Developing a Clinical Biomarker Method with External Resources

Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-SynucleinS

Dopamine-modified [alpha]-synuclein blocks chaperone-mediated autophagy

Impaired degradation of mutant [alpha]-synuclein by chaperone-mediated autophagy

Isolation and Characterization of Two Proteins fromMoraxella catarrhalis That Bear a Common Epitope

An evaluation of the molecular model of alpha-synuclein-mediated cytotoxicity

Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations

Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of Î±-Synuclein

Suchergebnisse filtern